Alphatec Holdings Inc ATEC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alphatec Holdings, Inc. - ATEC
ATEC Announces Participation in Upcoming Investor Conferences
Alphatec Holdings (ATEC) Securities Investigation Notice - Levi & Korsinsky
ATEC Investors Have Opportunity to Join Alphatec Holdings, Inc. Fraud Investigation with SBS Law
ATEC SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Alphatec Holdings
Alphatec Holdings Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Alphatec Holdings (ATEC)
ATEC Reports Third Quarter Financial Results
ATEC to Report Third Quarter 2026 Financial Results on October 29, 2026
Trading Information
- Previous Close Price
- $7.06
- Day Range
- $7.05–7.26
- 52-Week Range
- $6.81–23.29
- Bid/Ask
- $6.84 / $7.50
- Shares Outstanding
- 153.33M
- Market Cap
- $1.08B
- Volume/Avg
- 4M / 3M
Key Statistics
- Price/Earnings (Normalized)
- 94.74
- Price/Sales
- 1.31
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 913
- Website
- https://www.atecspine.com
Valuation
Metric | ATEC |
|---|---|
Price/Earnings (Normalized) | 94.74 |
Price/Book Value | — |
Price/Sales | 1.31 |
Price/Cash Flow | 8.35 |
Price/Earnings
ATEC
Financial Strength
Metric | ATEC |
|---|---|
Quick Ratio | 1.06 |
Current Ratio | 2.36 |
Interest Coverage | −0.92 |
Quick Ratio
ATEC
Profitability
Metric | ATEC |
|---|---|
Return on Assets (Normalized) | 4.53% |
Return on Equity (Normalized) | 4,266.56% |
Return on Invested Capital (Normalized) | 13.57% |
Return on Assets
ATEC
Medical Devices Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|T%gd>p | LOCK|ssY$ | $188B | |||
| Medtronic PLC MDT | LOCK|qXn?rB< | LOCK|v&Y>% | $132B | |||
| Stryker Corp SYK | LOCK|@%g&c%bc | LOCK|QJ& | $118B | |||
| Boston Scientific Corp BSX | LOCK|h#sWy$ | LOCK|Z@!? | $64B | |||
| Edwards Lifesciences Corp EW | LOCK|!Ggr@tt | LOCK|N!QL | $62B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|cN%zwbs | LOCK|%L | $38B | |||
| DexCom Inc DXCM | LOCK|p>C><QMd | LOCK|F?L@C | $31B | |||
| Koninklijke Philips NV ADR PHG | LOCK|lr | LOCK|Gq@ | $30B | |||
| Steris PLC STE | LOCK|h?Z#?N | LOCK|<rLZ | $26B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|W%GBZWG | LOCK|<F! | $20B |
United States